#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ichthyosis High-grade B-cell lymphoma Rhabdomyosarcoma Fibrosarcoma metastatic Fms-like tyrosine kinase 3 positive Round cell liposarcoma Small cell lung cancer extensive stage Antithrombin III deficiency Follicular lymphoma stage I Chronic myeloid leukaemia Marginal zone lymphoma Liposarcoma Subdural haematoma Congenital disorder of glycosylation Myasthenia gravis More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Von Willebrand’s disease Gaucher’s disease type I – Treatment Medulloblastoma – Trials in Disease Adrenogenital syndrome – Diagnostics Mitochondrial myopathy – Diagnostics VEXAS syndrome – Basic Information Mucopolysaccharidosis III – Basic Information Breast angiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fexofenadine Hydrochloride Arachis Hypogaea Extract [18F]-Altanserin Ubamatamab Edg-5506 RP2 ANHYDROUS CALCIUM FOLINATE Mocravimod Almagate Ganciclovir Sodium Astegolimab HYPOCHLOROUS ACID Davutamig Verapamil Caffeine Poractant Alfa Ademetionine Daptomycin Idarubicin Hydrochloride Lavender Oil More therapies…

    Learn about Your Condition

    Pancreatic fistula Paraganglion neoplasm Eye inflammation Hepatitis alcoholic Electrocorticogram Pancreatic neoplasm Cardiac amyloidosis Lennox-Gastaut syndrome Thymoma malignant Liver transplant rejection Breast cancer metastatic Renal cancer metastatic Deafness traumatic Malignant melanoma Hypophosphatasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Balcinrenone
    • Dapagliflozin
    Austria Bulgaria Czechia Finland France Germany +9

  • Study on Inhaled Levofloxacin and Sodium Chloride for Patients with Community-Acquired Pneumonia, Including Those with Pre-existing Lung Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Levofloxacin
    • Sodium Chloride
    Denmark

  • Study on Fludarabine, Melphalan, and ATG for Patients with Blood Cancer Undergoing Reduced Intensity Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Melphalan
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    Belgium

  • Study on the Effectiveness of 2LHERP in Reducing Recurrent Cold Sores in Patients with Frequent Outbreaks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Herpes simplex
    • Oral herpes
    Investigated Drugs:
    • Deoxyribonucleic Acid
    • Ribonucleic Acid
    • Specific Nucleic Acid Sna-Her1
    Belgium

  • Study on the Effectiveness and Safety of Apremilast for Patients Aged 6 and Older with Generalized Epidermolysis Bullosa Simplex

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Apremilast
    France

  • Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium Croatia Czechia France Germany +8
Previous Page
1 … 506 507 508 509 510 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!